Developing Insulin-like growth factor binding protein 2 (IGFBP2) peptide fragment-based therapeutics to treat functional and behavioral deficits in Ph

Project: Research project

Project Details


Our long-term goal is to develop an effective pharmacological treatment for a subset of ASD patients.
Determining feasibility in this study will prepare the company for further pre-clinical work and clinical testing in a Phase II STTR.
Effective start/end date11/18/198/31/21


  • AlisBio LLC (Agmt 11/27/19 // 1R41MH121140-01)
  • National Institute of Mental Health (Agmt 11/27/19 // 1R41MH121140-01)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.